779 |
The Latest Updates in DES Clinical Data |
Gregg W. Stone |
Jul. 22. 09 |
778 |
Does the Efficacy of Bivalirudin During PCI Depend on Clopidogrel Pretreatment? |
Matthew Price |
Jul. 22. 09 |
777 |
STEMI and NSTEMI Pharmacology Confusion: How to Choose and Use Antithrombins (Unfractionated and Low Molecular Weight Heparins, Bivalirudin, Fondaparinux) and Antiplatelet Agents (Aspirin, Clopidogrel, and Prasugrel) |
Gregg W. Stone |
Jul. 22. 09 |
776 |
Systemic Therapy for Plaque Stabilization: New Drugs Targeting LP-PLA2 |
Patrick W. Serruys |
Jul. 22. 09 |
775 |
Regional Therapy: FIH Experience of A Novel Self Expandable Nitinol Device |
Juan F. Granada |
Jul. 22. 09 |
774 |
In Search of Vulnerable Plaque: Summary of Current Issues |
Gary S. Mintz |
Jul. 22. 09 |
773 |
Mechanisms of Plaque Destabilization: Pathologic Observation |
Renu Virmani |
Jul. 22. 09 |
772 |
New Paradigms in Treatment of ACS/AMI |
Roxana Mehran |
Jul. 22. 09 |
771 |
BioMatrixTM: The New Biodegradable Abluminally Coated DES BioMatrixTM Clinical Program |
Teguh Santoso |
Jul. 22. 09 |
770 |
Asia Pacific BioMatrixTM Clinical Results |
Teguh Santoso |
Jul. 22. 09 |